February 9, 2023 To understand how we can feed and nourish the planet and her people, Agatha Wong speaks with Frank Jaksch, CEO of Ayana Bio, to understand how ingredients play a crucial role in shaping the food and beverage industry. See p. 34-35 of the publication.
READ THE ARTICLEFebruary 9, 2023 To understand how we can feed and nourish the planet and her people, Agatha Wong speaks with Frank Jaksch, CEO of Ayana Bio, to understand how ingredients play a crucial role in shaping the food and beverage industry. See p. 34-35 of the publication.
READ THE ARTICLEJanuary 19, 2023 The biological research company will cultivate polyphenol-rich cacao cells to add nutrition to a variety of food and drink items — but will not make candy.
READ THE ARTICLEJanuary 19, 2023 Plant cell tech firm Ayana Bio is pledging US$3 million to accelerate cacao bioactive production using cellular cultivation, part of a strategy to boost efforts in curbing the many challenges plaguing the cacao industry, such as climate change, deforestation and child labor.
READ THE ARTICLEJanuary 18, 2023 Ayana Bio – one of a new wave of startups seeking to unlock the potential of plant cell culture in the food and nutrition industry – is turning its attention to cacao bioactives with a $3m investment it claims will also benefit the wider industry.
READ THE ARTICLEJanuary 18, 2023 The initiative uses biotechnology to sustainably produce cacao bioactives and support genetic research to improve cacao plant varieties.
READ THE ARTICLEJanuary 4, 2023 With the last several years including a series of unprecedented events and challenges, Food Manufacture seeks the expertise of several food and drink leaders to find out what’s on the cards for 2023. Ayana Bio's CEO, Frank Jaksch, on trends regarding health beneficial products.
READ THE ARTICLESeptember 27, 2022 In an interview with the Orange County Business Journal, our CEO Frank Jaksch discusses how Ayana Bio accesses plant molecules that people have long co-opted as medicines and nutritional supplements. “Grow[ing] plants without having to grow plants,” complements traditional agriculture and bolsters supply chains hard hit by climate change and overharvest.
READ THE ARTICLEAugust 25, 2022 As he takes the helm of the Ginkgo Bioworks spinoff, CEO Frank Jaksch said its plant cell culture tech to create bioactive compounds from ginseng, berries, cocoa and ginger could be a game changer.
READ THE ARTICLEAugust 24, 2022 Plant cell technology company and Ginkgo Bioworks spin off Ayana Bio has appointed ChromaDex founder and former CEO Frank Jaksch as its new CEO.
READ THE ARTICLEAugust 24, 2022 Ayana Bio, the plant cell technology company making sustainable bioactives for consumer products, today announced the appointment of Frank Jaksch as the company's Chief Executive Officer.
READ THE ARTICLEAugust 24, 2022 Health and wellness industry veteran will lead the company to scale sustainable bioactives using plant cell technology instead of agriculture.
READ THE ARTICLEAugust 11, 2022 Iridoids can be found in thousands of bioactives from plants. But the ones most often found in nature make up only about a fourth of what is possible in theory. The work presented in this text--from the laboratory of Prof. Sarah O’Connor, Ayana Bio’s Chief Science Advisor--opens up the possibility of producing iridoids with geometries not often found in nature. These new molecules may have unique and interesting properties.
READ THE ARTICLEJuly 6, 2022 Prof. Sarah O’Connor and her team uncovered enzymes that complete the bioactive pathways of strychnine, diaboline, and brucine--molecules whose biosynthesis has eluded the broader scientific community for over 200 years. Her team then expressed the enzymes they identified in Nicotiana benthamiana to reconstitute the pathways in a living system as a case study to show that complex phytochemicals can be produced from a biotech chassis.
READ THE ARTICLESeptember 9, 2021 Ginkgo Bioworks ("Ginkgo"), which is building the leading horizontal platform for cell programming, today announced the launch of Ayana Bio to enable a healthier future by harnessing bioactive compounds for use as complementary medicine to support human health and wellness.
READ THE ARTICLEFebrury 9, 2023 To understand how we can feed and nourish the planet and her people, Agatha Wong speaks with Frank Jaksch, CEO of Ayana Bio, to understand how ingredients play a crucial role in shaping the food and beverage industry. See p. 34-35 of the publication.
January 19, 2023 The biological research company will cultivate polyphenol-rich cacao cells to add nutrition to a variety of food and drink items — but will not make candy.
January 19, 2023 Plant cell tech firm Ayana Bio is pledging US$3 million to accelerate cacao bioactive production using cellular cultivation, part of a strategy to boost efforts in curbing the many challenges plaguing the cacao industry, such as climate change, deforestation and child labor.
January 18, 2023 Ayana Bio – one of a new wave of startups seeking to unlock the potential of plant cell culture in the food and nutrition industry – is turning its attention to cacao bioactives with a $3m investment it claims will also benefit the wider industry.
January 18, 2023 The initiative uses biotechnology to sustainably produce cacao bioactives and support genetic research to improve cacao plant varieties.
January 4, 2023 With the last several years including a series of unprecedented events and challenges, Food Manufacture seeks the expertise of several food and drink leaders to find out what’s on the cards for 2023. Ayana Bio's CEO, Frank Jaksch, on trends regarding health beneficial products.
September 27, 2022 In an interview with the Orange County Business Journal, our CEO Frank Jaksch discusses how Ayana Bio accesses plant molecules that people have long co-opted as medicines and nutritional supplements. “Grow[ing] plants without having to grow plants,” complements traditional agriculture and bolsters supply chains hard hit by climate change and overharvest.
August 25, 2022 As he takes the helm of the Ginkgo Bioworks spinoff, CEO Frank Jaksch said its plant cell culture tech to create bioactive compounds from ginseng, berries, cocoa and ginger could be a game changer.
August 24, 2022 Plant cell technology company and Ginkgo Bioworks spin off Ayana Bio has appointed ChromaDex founder and former CEO Frank Jaksch as its new CEO.
August 24, 2022 Ayana Bio, the plant cell technology company making sustainable bioactives for consumer products, today announced the appointment of Frank Jaksch as the company's Chief Executive Officer.
August 24, 2022 Health and wellness industry veteran will lead the company to scale sustainable bioactives using plant cell technology instead of agriculture.
August 11, 2022: Iridoids can be found in thousands of bioactives from plants. But the ones most often found in nature make up only about a fourth of what is possible in theory. The work presented in this text--from the laboratory of Prof. Sarah O’Connor, Ayana Bio’s Chief Science Advisor--opens up the possibility of producing iridoids with geometries not often found in nature. These new molecules may have unique and interesting properties.
July 6, 2022: Prof. Sarah O’Connor and her team uncovered enzymes that complete the bioactive pathways of strychnine, diaboline, and brucine--molecules whose biosynthesis has eluded the broader scientific community for over 200 years. Her team then expressed the enzymes they identified in Nicotiana benthamiana to reconstitute the pathways in a living system as a case study to show that complex phytochemicals can be produced from a biotech chassis.
September 9, 2021: Ginkgo Bioworks ("Ginkgo"), which is building the leading horizontal platform for cell programming, today announced the launch of Ayana Bio to enable a healthier future by harnessing bioactive compounds for use as complementary medicine to support human health and wellness.